# Immediate Chemotherapy Following Resection for High-Risk Non-Muscle-Invasive Bladder Cancer

> **NCT06889623** · NA · RECRUITING · sponsor: **Changhai Hospital** · enrollment: 72 (estimated)

## Conditions studied

- NMIBC

## Interventions

- **PROCEDURE:** Immediate postoperative chemotherapy

## Key facts

- **NCT ID:** NCT06889623
- **Lead sponsor:** Changhai Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-01
- **Primary completion:** 2026-06-01
- **Final completion:** 2028-06-01
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2025-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06889623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06889623, "Immediate Chemotherapy Following Resection for High-Risk Non-Muscle-Invasive Bladder Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06889623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*